Featured Research

from universities, journals, and other organizations

Cost-effectiveness of HIV testing in drug abuse treatment programs demonstrated

Date:
September 9, 2012
Source:
Weill Cornell Medical College
Summary:
Less than half of community-based substance abuse treatment programs in the United States currently make HIV testing available on-site or through referral. A new study shows the cost-effectiveness of integrating on-site rapid HIV testing into drug treatment programs.

Less than half of community-based substance abuse treatment programs in the United States currently make HIV testing available on-site or through referral. A new study led by researchers at Weill Cornell Medical College shows the cost-effectiveness of integrating on-site rapid HIV testing into drug treatment programs.

Related Articles


The study, published in the September 9 issue of Drug and Alcohol Dependence, is a collaboration with the HIV Rapid Testing and Counseling Study trial, sponsored by the National Drug Abuse Clinical Trials Network. The randomized clinical trial conducted in 12 community-based substance abuse treatment programs in 2009 found that 80 percent of the participants offered on-site HIV testing with a rapid test accepted the testing offer and obtained test results, as compared with less than 20 percent of those referred for off-site testing. These recent results were published in the June issue of the American Journal of Public Health.

The new study measured the cost-effectiveness of on-site rapid HIV testing in drug abuse treatment programs using data from the HIV Rapid Testing and Counseling Study, including patient demographics, prior testing history, test acceptance and receipt of results, undiagnosed HIV prevalence and program costs. Researchers used the Cost Effectiveness of Preventing AIDS Complications (CEPAC) computer simulation model to project life expectancy, lifetime costs and quality-adjusted life years (QALYs) for the HIV-infected individuals. The researchers calculated the cost per QALY with and without on-site testing, also taking into account the costs associated with testing individuals who turn out not to be HIV-infected.

"Our cost-effectiveness analysis supports integrating HIV screening and prevention services with substance abuse treatment programs, which is called for in President Barack Obama's National HIV/AIDS Strategy, " says the study's lead investigator Dr. Bruce R. Schackman, an associate professor of public health and chief of the Division of Health Policy at Weill Cornell Medical College. "We found that on-site testing with a description of the testing procedure, without pre-test risk-reduction counseling, resulted in a beneficial cost-effectiveness ratio. This strategy provides better value than off-site referral."

Study results show a cost-effectiveness ratio of $60,300 per QALY, which is below one acceptable cost-effectiveness threshold of $100,000 per QALY used in the U.S. In addition, researchers found that participant-tailored risk-reduction counseling does not provide better value in this setting. Risk-reduction counseling increases the cost per participant by nearly 90 percent, and in the trial it had no significant effect on self-reported sexual risk behavior.

Although medical advances over the past 15 years have made HIV a substantially manageable illness, new HIV cases in the U.S. continue to emerge at a steady rate. More than 20 percent of infected individuals are unaware of their infection and are therefore not treated. This both reduces their life expectancy and quality of life and makes them more likely to transmit the infection to others. To identify more people infected with HIV, in 2006 the Centers for Disease Control and Prevention (CDC) recommended routine HIV screening for all adults in health care settings, as well as expanding testing in non-medical settings.

"This study shows that introducing on-site rapid HIV testing to substance abuse treatment programs should be an important element of the CDC's strategy to identify and treat HIV-infected persons earlier to improve their lives and reduce transmission," says study co-author Dr. Lisa R. Metsch, the Stephen Smith professor and chair of sociomedical sciences at the Mailman School of Public Health at Columbia University and the principal investigator of the initial HIV Rapid Testing and Counseling Study. "The study provides strong evidence of the societal value of on-site HIV testing. We need to overcome barriers to implementing HIV testing in non-medical settings for those not recently tested."

"The study reinforces the clinical and economic value of offering on-site rapid HIV testing in drug abuse treatment programs by demonstrating its cost-effectiveness," says senior author Dr. Rochelle P. Walensky, associate professor of medicine at Harvard Medical School and Massachusetts General Hospital. "Our study should serve as motivation for policymakers and substance abuse treatment leaders to seek funding for on-site rapid HIV testing in substance abuse treatment programs."

The study's co-authors include Dr. Grant N. Colfax and Dr. Tim Matheson from the San Francisco Department of Public Health; Jared A. Leff from Weill Cornell Medical College; Angela Wong and Callie A. Scott from Massachusetts General Hospital; Dr. Daniel J. Feaster and Dr. Lauren Gooden from the University of Miami, Miller School of Medicine; Louise F. Haynes of the Medical University of South Carolina; and Dr. A. David Paltiel of Yale School of Public Health.

The study was supported by the National Institute on Drug Abuse, the National Drug Abuse Treatment Clinical Trials Network, the National Institute of Mental Health, and the National Institute of Allergy and Infectious Diseases.


Story Source:

The above story is based on materials provided by Weill Cornell Medical College. Note: Materials may be edited for content and length.


Journal Reference:

  1. Bruce R. Schackman, Lisa R. Metsch, Grant N. Colfax, Jared A. Leff, Angela Wong, Callie A. Scott, Daniel J. Feaster, Lauren Gooden, Tim Matheson, Louise F. Haynes, A. David Paltiel, Rochelle P. Walensky. The cost-effectiveness of rapid HIV testing in substance abuse treatment: Results of a randomized trial. Drug and Alcohol Dependence, 2012; DOI: 10.1016/j.drugalcdep.2012.08.009

Cite This Page:

Weill Cornell Medical College. "Cost-effectiveness of HIV testing in drug abuse treatment programs demonstrated." ScienceDaily. ScienceDaily, 9 September 2012. <www.sciencedaily.com/releases/2012/09/120909150233.htm>.
Weill Cornell Medical College. (2012, September 9). Cost-effectiveness of HIV testing in drug abuse treatment programs demonstrated. ScienceDaily. Retrieved December 22, 2014 from www.sciencedaily.com/releases/2012/09/120909150233.htm
Weill Cornell Medical College. "Cost-effectiveness of HIV testing in drug abuse treatment programs demonstrated." ScienceDaily. www.sciencedaily.com/releases/2012/09/120909150233.htm (accessed December 22, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, December 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Earthworms Provide Cancer-Fighting Bacteria

Earthworms Provide Cancer-Fighting Bacteria

Reuters - Innovations Video Online (Dec. 21, 2014) Polish scientists isolate bacteria from earthworm intestines which they say may be used in antibiotics and cancer treatments. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Reuters - Innovations Video Online (Dec. 21, 2014) A team of scientists led by Danish chemist Jorn Christensen says they have isolated two chemical compounds within an existing antipsychotic medication that could be used to help a range of failing antibiotics work against killer bacterial infections, such as Tuberculosis. Jim Drury went to meet him. Video provided by Reuters
Powered by NewsLook.com
Hugging It Out Could Help You Ward Off A Cold

Hugging It Out Could Help You Ward Off A Cold

Newsy (Dec. 21, 2014) Carnegie Mellon researchers found frequent hugs can help people avoid stress-related illnesses. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins